<?xml version="1.0" encoding="UTF-8"?>
<ref id="B299-pharmaceuticals-14-00381">
 <label>299.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kabir</surname>
    <given-names>M.T.</given-names>
   </name>
   <name>
    <surname>Uddin</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Hossain</surname>
    <given-names>M.F.</given-names>
   </name>
   <name>
    <surname>Abdulhakim</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Alam</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Ashraf</surname>
    <given-names>G.M.</given-names>
   </name>
   <name>
    <surname>Bungau</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Bin-Jumah</surname>
    <given-names>M.N.</given-names>
   </name>
   <name>
    <surname>Abdel-Daim</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Aleya</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>nCOVID-19 Pandemic from Molecular Pathogenesis to Potential Investigational Therapeutics</article-title>
  <source>Front. Cell Dev. Biol.</source>
  <year>2020</year>
  <volume>8</volume>
  <fpage>616</fpage>
  <pub-id pub-id-type="doi">10.3389/fcell.2020.00616</pub-id>
  <pub-id pub-id-type="pmid">32754599</pub-id>
 </element-citation>
</ref>
